34 related articles for article (PubMed ID: 27221204)
1. Statin treatment is associated with a negative correlation between NT-proBNP and insulin resistance in patients without history of heart failure.
Wang JS; Lee CL; Lee WJ; Lee IT; Lin SY; Lee WL; Liang KW; Sheu WH
Clin Chim Acta; 2016 Aug; 459():84-88. PubMed ID: 27221204
[TBL] [Abstract][Full Text] [Related]
2. Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.
Walford GA; Ma Y; Christophi CA; Goldberg RB; Jarolim P; Horton E; Mather KJ; Barrett-Connor E; Davis J; Florez JC; Wang TJ;
Diabetologia; 2014 May; 57(5):935-9. PubMed ID: 24554005
[TBL] [Abstract][Full Text] [Related]
3. Insulin Resistance and N-Terminal Pro-B-Type Natriuretic Peptide Among Healthy Adults.
Echouffo-Tcheugui JB; Zhang S; McEvoy JW; Juraschek SP; Fang M; Ndumele CE; Christenson RH; Selvin E
JAMA Cardiol; 2023 Oct; 8(10):989-995. PubMed ID: 37672260
[TBL] [Abstract][Full Text] [Related]
4. Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic Syndrome.
Krzesiński P; Piechota W; Piotrowicz K; Gielerak G; Woźniak-Kosek A
Cardiol Res Pract; 2019; 2019():8571795. PubMed ID: 31929901
[TBL] [Abstract][Full Text] [Related]
5. Association between antioxidant metabolites and N-terminal fragment brain natriuretic peptides in insulin-resistant individuals.
Anwardeen N; Naja K; Elrayess MA
Cardiovasc Endocrinol Metab; 2024 Jun; 13(2):e0303. PubMed ID: 38706534
[TBL] [Abstract][Full Text] [Related]
6. Gut permeability, circulating bacterial fragments and measures of congestion in peritoneal dialysis.
Li C; Ng JK; Chan GC; Fung WW; Lai KB; Poon PY; Luk CC; Chow KM; Szeto CC
Clin Kidney J; 2024 Mar; 17(3):sfae056. PubMed ID: 38516523
[TBL] [Abstract][Full Text] [Related]
7. Editor's Choice-Biomarkers of acute cardiovascular and pulmonary diseases.
Suzuki T; Lyon A; Saggar R; Heaney LM; Aizawa K; Cittadini A; Mauro C; Citro R; Limongelli G; Ferrara F; Vriz O; Morley-Smith A; Calabrò P; Bossone E
Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):416-33. PubMed ID: 27221957
[TBL] [Abstract][Full Text] [Related]
8. Circulating Omentin-1 Levels Are Decreased in Dilated Cardiomyopathy Patients with Overt Heart Failure.
Huang Y; Lin Y; Zhang S; Wang Z; Zhang J; Chang C; Liu L; Ji Q; Liu X
Dis Markers; 2016; 2016():6762825. PubMed ID: 27313334
[TBL] [Abstract][Full Text] [Related]
9. Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspnea.
Stokes NR; Dietz BW; Liang JJ
Open Access Emerg Med; 2016; 8():35-45. PubMed ID: 27307771
[TBL] [Abstract][Full Text] [Related]
10. The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.
Kube J; Ebner N; Jankowska EA; Rozentryt P; Cicoira M; Filippatos GS; Ponikowski P; Doehner W; Anker SD; von Haehling S
Int J Cardiol; 2016 Sep; 219():84-91. PubMed ID: 27288971
[TBL] [Abstract][Full Text] [Related]
11. Spotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to date.
Vilela-Martin JF
Drug Des Devel Ther; 2016; 10():1627-39. PubMed ID: 27274196
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of biomarkers in stroke.
Iemolo F; Sanzaro E; Duro G; Giordano A; Paciaroni M
Immun Ageing; 2016; 13():19. PubMed ID: 27247610
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Drug-Drug Interaction Potential Between Atorvastatin and LCZ696, A Novel Angiotensin Receptor Neprilysin Inhibitor, in Healthy Chinese Male Subjects.
Ayalasomayajula S; Pan W; Han Y; Yang F; Langenickel T; Pal P; Zhou W; Yuan Y; Rajman I; Sunkara G
Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):309-318. PubMed ID: 27245340
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes after transcatheter aortic valve implantation: the impact of intraoperative tissue Doppler echocardiography.
Eidet J; Dahle G; Bugge JF; Bendz B; Rein KA; Aaberge L; Offstad JT; Fosse E; Aakhus S; Halvorsen PS
Interact Cardiovasc Thorac Surg; 2016 Sep; 23(3):403-9. PubMed ID: 27241050
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of natriuretic peptides and troponins in hypertrophic cardiomyopathy.
Kehl DW; Buttan A; Siegel RJ; Rader F
Int J Cardiol; 2016 Sep; 218():252-258. PubMed ID: 27236124
[TBL] [Abstract][Full Text] [Related]
16. Extremely elevated BNP in acute heart failure: Patient characteristics and outcomes.
Omar HR; Guglin M
Int J Cardiol; 2016 Sep; 218():120-125. PubMed ID: 27232923
[TBL] [Abstract][Full Text] [Related]
17. Prognostic utility of combination of NT-proBNP with high sensitive cTn I in patients with heart failure: Results from retrospective study in an emergency department.
Cheng H; Fan WZ; Wang SC; Geng J; Zang HL; Shen XH; Liu ZH; Wang LZ
Scand J Clin Lab Invest; 2016 Sep; 76(5):361-7. PubMed ID: 27228479
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles.
Wurm R; Resl M; Neuhold S; Prager R; Brath H; Francesconi C; Vila G; Strunk G; Clodi M; Luger A; Pacher R; Hülsmann M
Heart; 2016 Oct; 102(19):1544-51. PubMed ID: 27226327
[TBL] [Abstract][Full Text] [Related]
19. HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.
Piek A; Meijers WC; Schroten NF; Gansevoort RT; de Boer RA; Silljé HH
J Card Fail; 2017 Jan; 23(1):12-19. PubMed ID: 27224553
[TBL] [Abstract][Full Text] [Related]
20. Independent and joint associations between the triglyceride-glucose index and NT-proBNP with the risk of adverse cardiovascular events in patients with diabetes and acute coronary syndrome: a prospective cohort study.
Wang M; Zhou L; Su W; Dang W; Li H; Chen H
Cardiovasc Diabetol; 2023 Jun; 22(1):149. PubMed ID: 37365593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
